These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1829534)

  • 1. Social isolation and cohabitation with haloperidol-treated partners: effect on density of striatal dopamine D2 receptors in the developing rat brain.
    Bean G; Lee T
    Psychiatry Res; 1991 Mar; 36(3):307-17. PubMed ID: 1829534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of ethanol and haloperidol on dopamine receptor (D2) density.
    Fuchs V; Coper H; Rommelspacher H
    Neuropharmacology; 1987 Aug; 26(8):1231-3. PubMed ID: 3658125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic nicotine use blocks haloperidol-induced increase in striatal D2-dopamine receptor density.
    Prasad C; Spahn SA; Ikegami H
    Biochem Biophys Res Commun; 1989 Feb; 159(1):48-52. PubMed ID: 2522303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential modulation of dopamine D2 receptors by chronic haloperidol, nitrendipine, and pimozide.
    Tecott LH; Kwong LL; Uhr S; Peroutka SJ
    Biol Psychiatry; 1986 Oct; 21(12):1114-22. PubMed ID: 2428411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic haloperidol affects striatal D2-dopamine receptor reappearance after irreversible receptor blockade.
    Pich EM; Benfenati F; Farabegoli C; Fuxe K; Meller E; Aronsson M; Goldstein M; Agnati LF
    Brain Res; 1987 Dec; 435(1-2):147-52. PubMed ID: 2962698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D2 receptors in the striatum and frontal cortex following chronic administration of haloperidol.
    Liskowsky DR; Potter LT
    Neuropharmacology; 1987 May; 26(5):481-3. PubMed ID: 2955242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
    Wilmot CA; Szczepanik AM
    Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy.
    Calderon SF; Sanberg PR; Norman AB
    Brain Res; 1988 May; 450(1-2):403-7. PubMed ID: 2969764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic haloperidol does not alter agonist affinity for dopamine receptors in vitro.
    Meller E; Bohmaker K; Goldstein M; Schweitzer JW; Friedhoff AJ
    Eur J Pharmacol; 1985 Mar; 109(3):389-94. PubMed ID: 3157587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of striatal dopamine D2 receptor acquisition following prenatal neuroleptic exposure.
    Schmidt MH; Lee T
    Psychiatry Res; 1991 Mar; 36(3):319-28. PubMed ID: 1676523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pertussis toxin on D2-dopamine receptor in rat striatum: evidence for coupling of Ni regulatory protein with D2-receptor.
    Fujita N; Nakahiro M; Fukuchi I; Saito K; Yoshida H
    Brain Res; 1985 May; 333(2):231-6. PubMed ID: 3158374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol.
    Memo M; Pizzi M; Missale C; Carruba MO; Spano PF
    Neuropharmacology; 1987 May; 26(5):477-80. PubMed ID: 2955241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the time course of haloperidol-induced up-regulation of rat striatal and mesolimbic dopamine receptors.
    Prosser ES; Csernansky JG; Hollister LE
    Life Sci; 1988; 43(8):715-20. PubMed ID: 2901023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal haloperidol alters striatal dopamine and opiate receptors.
    Moon SL
    Brain Res; 1984 Dec; 323(1):109-13. PubMed ID: 6098328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different plasticity changes in D1 and D2 receptors in rat striatal subregions following impairment of dopaminergic transmission.
    Savasta M; Dubois A; Benavidès J; Scatton B
    Neurosci Lett; 1988 Feb; 85(1):119-24. PubMed ID: 2834672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chronic haloperidol treatment on stimulated synaptic overflow of dopamine in the rat striatum.
    Wiedemann DJ; Garris PA; Near JA; Wightman RM
    J Pharmacol Exp Ther; 1992 May; 261(2):574-9. PubMed ID: 1533666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of haloperidol on dopamine receptor gene expression.
    Fox CA; Mansour A; Watson SJ
    Exp Neurol; 1994 Dec; 130(2):288-303. PubMed ID: 7867758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of estradiol and haloperidol on hypophysectomized rat brain dopamine receptors.
    Di Paolo T; Daigle M; Labrie F
    Psychoneuroendocrinology; 1984; 9(4):399-404. PubMed ID: 6514934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride.
    Prosser ES; Pruthi R; Csernansky JG
    Psychopharmacology (Berl); 1989; 99(1):109-16. PubMed ID: 2506596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.